Anastasiya O. Sitkovskaya

Anastasiya O. Sitkovskaya

Auto-generated profile, based on publicly available information

Anastasiya O. Sitkovskaya

National Medical Research Centre for Oncology

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2022 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
OKOleg Ivanovich Kit
Oleg Ivanovich Kit
Sofia Vladimirovna TimofeevaSofia Vladimirovna Timofeeva
Sofia Vladimirovna Timofeeva
ASAnastasia O. Sitkovskaya
Anastasia O. Sitkovskaya
INInna A. Novikova
Inna A. Novikova
EKEvgeniy N. Kolesnikov
Evgeniy N. Kolesnikov
Biobanks are the platform for innovative biomedical research in the field of translational and personalized medicine. The important aspect for conducting large-scale research in the field of genomics, transcriptomics, proteomics is the availability of a sample information of the documented high-resolution samples. The biobanks solve the problem of forming groups of patients with different nosology within the population of interest and provide clinical and laboratory information on each sample. The aim of this article is to describe the Biobank processes of the National Medical Research Centre for Oncology within the framework of existing projects and build up collections. The review discusses the main stages of the systematized biobank process, describes the methods of sample preparation of different types of biological material, and also provides statistics of the build up collections. To this date, the predominant part of the depository consists of tissue samples of patients diagnosed with colorectal cancer 24% and stomach cancer 23% of the total number of tissue samples, while the number of tissue samples of pancreatic cancer is 10%, and esophageal cancer and breast cancer 22%. In addition to tissue samples, the biobank of the National Medical Research Centre for Oncology stores 24 cell lines of a human origin and the collection of 200 microbiota samples: 100 are from patients diagnosed with lung cancer and 100 from conditional healthy donors. Currently, the studies have been performed on biomaterial from the biobank build up collections to search for prognostic biomarkers and potential targets for targeted therapy by using high-throughput sequencing in patients diagnosed with pancreatic cancer and brain cancer. Thus, the collections play an important role for research in the field of personalized medicine, providing early diagnosis and effective treatment for each patient.

7 March 2020 in South Russian Journal of Cancer
Verified
Journal Article
Open access
PDF file
TST. V. Shamova
T. V. Shamova
ASA. O. Sitkovskaya
A. O. Sitkovskaya
LVL. N. Vashchenko
L. N. Vashchenko
EKE. E. Kechedzhieva
E. E. Kechedzhieva
The immune system plays an important role in the development and treatment of many cancer types. This fact determined the emergence of numerous immunotherapeutic approaches, including that of adoptive cell therapy (ACT). In this article, we set out to describe the basic methods of adoptive cell cancer therapy, their application and development prospects. The first part of the article deals with the significance of immunotherapeutic methods for cancer treatment and describes the current state of the problem. The main part of the article provides information on the mechanisms of adoptive T cell (unmodified and genetically modified) transfer, the creation of dendritic cell vaccines and cytokine-induced killers (CIK). In addition, a review of recent achievements in the introduction of the aforementioned methods into the clinical practice is carried out. The conclusion is made that adoptive cell therapy can be considered as one of the most promising methods of cancer immunotherapy, which should be optimized for more effective use in the treatment of cancer.

1 September 2022 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
Sofia Vladimirovna TimofeevaSofia Vladimirovna Timofeeva
Sofia Vladimirovna Timofeeva
SFSvetlana Светлана Filippova
Svetlana Светлана Filippova
ASA. O. Sitkovskaya
A. O. Sitkovskaya
NGN. V. Gnennaya
N. V. Gnennaya
IMI. V. Mezhevova
I. V. Mezhevova
OKOleg Ivanovich Kit
Oleg Ivanovich Kit
The Biobank of the National Medical Research Center of Oncology is a multi-layered infrastructure with large collections of biological samples, complemented by extensive and well-annotated clinical and pathological patient data, including medical images, pathological histology, and molecular analysis of biosamples. To date, the biobank of the National Medical Research Center of Oncology contains collections of primary and immortalized cancer cell lines of human origin. The collection of primary cell lines was formed from samples of postoperative material taken during the removal of tumors of various localizations (breast cancer, prostate cancer, lung cancer). All cell lines underwent internal quality control for contaminants (exogenous viruses, mycoplasmas and bacterial L-forms), viability and were cultivated without antibiotics. On the basis of the collected samples, a significant number of projects in the field of biomedicine were carried out, the results of which are described in this article.

17 July 2022 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
OKOleg Ivanovich Kit
Oleg Ivanovich Kit
VMV. I. Minkin
V. I. Minkin
ELE. A. Lukbanova
E. A. Lukbanova
YSYu. A. Sayapin
Yu. A. Sayapin
EGE. A. Gusakov
E. A. Gusakov
ЮСЮ. А. Саяпин
Ю. А. Саяпин
The aim. To study the toxicity of 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone in vitro and in vivo.Materials and methods. 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone was synthesized using a method for expanding the o-quinone cycle during the reaction between 5-nitro-2,6,8-trimethyl4-chloroquinoline and 3,4,5,6-tetrachloro-1,2-benzoquinone while boiled in dioxane. An in vitro experiment was carried out in the human A549 cell line. Cell viability was assessed using the MTT colorimetric assay by reducing the optical density of the experimental samples compared with the control ones. Acute toxicity was studied on 20 BALB/c Nude male mice. The test compound was administered once orally as a suspension in 1% starch gel at three doses: 0.0055 (group 1), 0.055 (group 2) and 0.55 mg / g (group 3). The control group (group 4) received a placebo.Results. We synthesized a new compound, 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone. Its structure was established by 1 H nuclear magnetic resonance (NMR), infrared (IR) spectroscopy, and mass spectrometry. The yield was 19.8 g (52%), the melting point was 205–207 ºС, bright yellow crystals (benzene) were observed. The half-maximal inhibitory concentration (IC50) of 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone was 0.21 ± 0.01 μM, which was significantly lower (р < 0.05) than the IC50 of cisplatin (3.84 ± 0.23). Following the in vivo experiment, no toxic effect of tropolone was detected when administered once at a dose of 0.0055, 0.055, and 0.55 mg / g. Conclusion. 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone demonstrated cytotoxic effects on the A549 cell line at a lower IC50 than cisplatin which is widely used in treatment of cancers, including lung cancer. Insolubility of 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone in water and the absence of its toxic effect in the studied modes determine the scope of its application for further study of cumulative and antitumor effects.

27 August 2020 in South Russian Journal of Cancer
Verified
Journal Article
Open access
PDF file
IMI. V. Mezhevova
I. V. Mezhevova
ASA. O. Sitkovskaya
A. O. Sitkovskaya
OKOleg Ivanovich Kit
Oleg Ivanovich Kit
Over the past decades, transplantable cell lines have been an affordable model for studying the biology and effect of chemotherapeutic drugs on tumors. However, numerous studies have shown that these cell lines are not heterogeneous enough and cannot reflect the drug resistance of tumors that occurs in some patients. Primary cell line cultures isolated from solid tumors have become widespread in personalized cancer therapy. This review discusses the basic methods for the preparation and cultivation of primary cell lines. A brief description is given of the methods for the disaggregation of tumor material using enzymatic, chemical and mechanical dissociation. The systems of cultivation of primary cell cultures. The selection of an appropriate dissociation method and cultivation is important to preserve the benefits of primary culture in preclinical studies.

10 February 2022 in Journal of Medical and Biological Research
Verified
Journal Article
Closed access
PDF file
NONational Medical Research Centre for Oncology
National Medical Research Centre for Oncology
SFSvetlana Светлана Filippova
Svetlana Светлана Filippova
ASAnastasiya O. Sitkovskaya
Anastasiya O. Sitkovskaya
LVLarisa N. Vashchenko
Larisa N. Vashchenko
ЭКЭмма Эдуардовна Кечеджиева
Эмма Эдуардовна Кечеджиева
АСАнастасия Олеговна Ситковская
Анастасия Олеговна Ситковская
In modern experimental oncology, 3D cell cultures have become particularly important, as they provide more relevant results compared to traditional 2D cultures. The problem of obtaining relevant cell models remains urgent for the study of breast cancer. One of the most common techniques for obtaining a 3D culture is the hanging drop method. Researchers are constantly developing its modifications to reduce variations in the shape and size of the resulting cell spheroids. One of the ways to solve this problem is to apply a hydrophobic coating to the surface of cell culture plastics. Silicones or Parafilm® laboratory films are often used for this purpose. As a result, the curvature of the drop surface increases, which leads to accelerated aggregation of cells in the centre of the drop. The purpose of this research was to evaluate the possibility of applying a coating made of the silicone elastomer SIEL 159-330 (Russia) to modify the hanging drop method. Materials and methods. We used the SIEL 159-330 coating cured at a temperature lower than that recommended by the manufacturer and investigated its cytotoxic properties as well as its effect on the formation of cell spheroids in a hanging drop. The material for the study was the BT-474 breast cancer cell line. Results. The research found that the tested elastomer has no effect on cell viability. At the same time, SIEL 159-330, compared to polystyrene, significantly reduces the time of cell aggregate formation in the lower part of the drop. In addition, cell spheroids of the breast cancer culture obtained on the SIEL 159-330 coating vary less in shape and size than spheroids obtained on the polystyrene or Parafilm coating.